News

Lupin receives USFDA approval for its generic version of Tolvaptan tablets, indicated for autosomal dominant polycystic ...
A physical therapist was shocked to learn that for her, some of her crucial organs had an expiration date. With proactive ...
Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of ...
Pharma major Lupin Ltd on Thursday said it has  received approval from the US health regulator for its generic version of ...
BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...
Shawn Kortes, known for his philanthropic work in the community, started dialysis this year and is searching for a kidney ...
Polycystic kidney disease (PKD) is a genetic disorder whereby a large number of cysts develop primarily within the kidneys, but also in other organs. PKD can be autosomal dominant (one mutated ...
Autosomal dominant polycystic kidney disease rates in the Military Health System are comparable to the general population, ...
Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.
Utah GM Justin Zanik recently celebrated the one-year anniversary of his kidney transplant and is back with the Jazz ...
Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).